Search details
1.
A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma.
Pediatr Blood Cancer
; 63(1): 39-46, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26235333
2.
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.
Genome Med
; 16(1): 28, 2024 Feb 12.
Article
in English
| MEDLINE | ID: mdl-38347552
Results
1 -
2
de 2
1
Next >
>>